Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571).
| Image |  |
|---|---|
| Description | scientific article published on 22 August 2002 |
| Author/s |
author: Oliver Ottmann |
| Publication date | August 22, 2002 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |